| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Tannenbaum Renee P is a Director at ANI PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 2 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | ANIP Ani Pharmaceuticals Inc | Director | Sell | 1,800 | $81.15 | $146,070.00 | -6.7% | -7.5% | - | |
| Dec 12, 2024 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $3.42 | $34,224.00 | +100.0% | +26.9% | -26.9% | |
| May 16, 2024 | ANIP Ani Pharmaceuticals Inc | Director | Sell | 2,000 | $63.87 | $127,740.00 | -9.9% | -7.2% | -5.9% | |
| Sep 15, 2022 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $1.72 | $17,168.00 | +156.3% | -15.6% | +3.6% |